Cadus Management Performance

Cadus Corporation -- USA Stock  

USD 1.58  0.01  0.64%

Analysis of Cadus manpower and management performance can provide insight into Cadus stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Cadus future performance. Please see also Stocks Correlation.

Cadus Management Effectiveness

The company has return on total asset (ROA) of (3.91) % which means that it has lost $3.91 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (6.72) % meaning that it created substantial loss on money invested by shareholders.

Cadus Insider Trading

Cadus Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of thirty-nine. Cadus Price Series Summation is a cross summation of Cadus price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

Cadus Stakeholders

Hunter Gary CEO and President and Director
David Blitz CFO, Principal Accounting Officer, Treasurer and Secretary
Jack Wasserman Independent Director
Peter Liebert Independent Director, Ph.D
James Broach Director of Research and Director, Ph.D

Leadership

Cadus Top Executives
Hunter Gary  CEO
CEO and President and Director

Tenure Analysis

Cadus Employment Tenure
Cadus employes about 5 people. The company is managed by 5 executives with total tenure of roughly 40 years, averanging almost 8.0 years of service per executive having 1.0 employee per reported executive.

Manpower Efficiency

Return on Cadus Manpower
Net Loss Per Employee 532 K
Net Loss Per Executive 532 K
Working Capital Per Employee 8.2 M
Working Capital Per Executive 8.2 M

Number of Employees

Cadus Number of Employees Analysis
Cadus Corporation is rated below average in number of employees category among related companies. The total workforce of Biotechnology industry is now estimated at about 11,807. Cadus adds roughly 5.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Please see also Stocks Correlation. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.